HVTN:100 A phase 1-2 randomized, double-blind, placebo-controlled clinica to support the development and clinical evaluation of an HIV vaccine regimen, in the region of the globe most heavily burdened by the HIV epidemic, specifically clade C epidemic in Southern Africa